Sandor Fritsch

A Clinical Trial of a Whole-Virus H5N1 Vaccine Derived from Cell Culture

Hartmut J. Ehrlich, Markus Müller, Helen May‐Lin Oh et al. · New England Journal of Medicine · 2008 · 274 citations · Full text

Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight

Sven Björkman, Myungshin Oh, Gerald Spotts et al. · Blood · 2011 · 204 citations · Full text

Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease

Joan Cox Gill, Giancarlo Castaman, Jerzy Windyga et al. · Blood · 2015 · 153 citations · Full text

Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial

Nina Wressnigg, Eva-Maria Pöllabauer, Gerald Aichinger et al. · The Lancet Infectious Diseases · 2013 · 100 citations

Vaccination, Vaccine Safety, Vaccine Development +9

Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial

Perry Barrett, Gregory P. Berezuk, Sandor Fritsch et al. · The Lancet · 2011 · 100 citations

Vaccinology, Vaccine Safety, Cross-protection +9